Association of Helicobacter pylori Infection With Reduced Risk for Esophageal Cancer Is Independent of Environmental and Genetic Modifiers

Gastroenterology

Volumn 139, Issue 1, 2010, Pages 73-83

  Whiteman, David C ^a   Parmar, Priya ^a   Fahey, Paul ^a   Moore, Suzanne P ^a   Stark, Mitchell ^a   Zhao, Zhen Zhen ^a   Montgomery, Grant W ^a   Green, Adèle C ^a   Hayward, Nicholas K ^a   Webb, Penelope M ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Acid Reflux; Case Control Studies; Esophageal Neoplasms; Genetic and Environmental Modifiers

Indexed keywords

ACETYLSALICYLIC ACID; BACTERIUM ANTIBODY; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; RISK REDUCTION; SEROPREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77953892533     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.04.009     Document Type: Article

References (56)

1. Ferlay J., Bray F., Pisani P., et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide (2004), International Agency for Research on Cancer, Lyon Base No. 5. version 2.0, IARC Press
2. Blot W.J., and McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 26 (1999) 2-8
3. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
4. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma (comments). N Engl J Med 340 (1999) 825-831
5. Gammon M.D., Schoenberg J.B., Ahsan H., et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia (comments). J Natl Cancer Inst 89 (1997) 1277-1284
6. Kabat G.C., Ng S.K., and Wynder E.L. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control 4 (1993) 123-132
7. Kubo A., and Corley D.A. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 872-878
8. Lagergren J., Bergstrom R., Lindgren A., et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85 (2000) 340-346
9. Mayne S.T., and Navarro S.A. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr 132 (2002) S3467-S3470
10. Vaughan T.L., Davis S., Kristal A., et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4 (1995) 85-92
11. Lagergren J. Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol 7 (2006) 347-349
12. Lagergren J., Bergstrom R., and Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130 (1999) 883-890
13. Whiteman D.C., Sadeghi S., Pandeya N., et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 57 (2008) 173-180
14. Pandeya N., Williams G., Green A.C., et al. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology 136 (2009) 1215-1224
15. Pandeya N., Williams G.M., Sadhegi S., et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am J Epidemiol 168 (2008) 105-114
16. Kjaerheim K., Gaard M., and Andersen A. The role of alcohol, tobacco, and dietary factors in upper aerogastric tract cancers: a prospective study of 10,900 Norwegian men. Cancer Causes Control 9 (1998) 99-108
17. Launoy G., Milan C., Faivre J., et al. Tobacco type and risk of squamous cell cancer of the oesophagus in males: a French multicentre case-control study. Int J Epidemiol 29 (2000) 36-42
18. Wei W.Q., Abnet C.C., Qiao Y.L., et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79 (2004) 80-85
19. Isaacson C. The change of the staple diet of black South Africans from sorghum to maize (corn) is the cause of the epidemic of squamous carcinoma of the oesophagus. Med Hypotheses 64 (2005) 658-660
20. Sitas F., Urban M., Stein L., et al. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer 2 (2007) 6
21. Islami F., Pourshams A., Nasrollahzadeh D., et al. Tea drinking habits and oesophageal cancer in a high-risk area in northern Iran: population based case-control study. BMJ 338 (2009) b929
22. Blaser M.J. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila Pa) 1 (2008) 308-311
23. Islami F., and Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila Pa) 1 (2008) 329-338
24. Shiotani A., Miyanishi T., Uedo N., et al. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index. Helicobacter 10 (2005) 373-378
25. Sykora J., Malan A., Zahlava J., et al. Gastric emptying of solids in children with H pylori-positive and H pylori-negative non-ulcer dyspepsia. J Pediatr Gastroenterol Nutr 39 (2004) 246-252
26. McColl K.E., el-Omar E., and Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 29 (2000) 687-703
27. Bahmanyar S., Zendehdel K., Nyren O., et al. Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers. Gut 56 (2007) 464-468
28. McColl K.E. Helicobacter pylori and oesophageal cancer-not always protective. Gut 56 (2007) 457-459
29. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
30. Jang W.H., Yang Y.I., Yea S.S., et al. The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166 (2001) 41-46
31. Gorouhi F., Islami F., Bahrami H., et al. Tumour-necrosis factor-α polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer 98 (2008) 1443-1451
32. Spechler S.J., Dixon M.F., Genta R., et al. Adenocarcinoma of the oesophago-gastric junction. In: Hamilton S.R., and Aaltonen L.A. (Eds). Pathology and genetics. Tumours of the digestive system. WHO classification of tumours Volume 2 (2000), Lyon IARC Press
33. Olsen C.M., Green A.C., Whiteman D.C., et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43 (2007) 690-709
34. Murray L., Johnston B., Lane A., et al. Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol 32 (2003) 645-650
35. Hampel H., Abraham N.S., and El-Serag H.B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143 (2005) 199-211
36. Doecke J., Zhao Z.Z., Pandeya N., et al. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer 123 (2008) 174-180
37. Ye W., Held M., Lagergren J., et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 96 (2004) 388-396
38. Wu A.H., Crabtree J.E., Bernstein L., et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103 (2003) 815-821
39. Banatvala N., Mayo K., Megraud F., et al. The cohort effect and Helicobacter pylori. J Infect Dis 168 (1993) 219-221
40. Webb P.M., Knight T., Greaves S., et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 308 (1994) 750-753
41. Moujaber T., MacIntyre C.R., Backhouse J., et al. The seroepidemiology of Helicobacter pylori infection in Australia. Int J Infect Dis 12 (2008) 500-504
42. Everhart J.E., Kruszon-Moran D., Perez-Perez G.I., et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 181 (2000) 1359-1363
43. Thjodleifsson B., Asbjornsdottir H., Sigurjonsdottir R.B., et al. Seroprevalence of Helicobacter pylori and cagA antibodies in Iceland, Estonia, and Sweden. Scand J Infect Dis 39 (2007) 683-689
44. Rokkas T., Pistiolas D., Sechopoulos P., et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 5 (2007) 1413-1417
45. Nyren O., and Blot W.J. Helicobacter pylori infection: mainly foe but also friend?. J Natl Cancer Inst 98 (2006) 1432-1434
46. Kamangar F., Dawsey S.M., Blaser M.J., et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 98 (2006) 1445-1452
47. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201
48. Blaser M.J., and Atherton J.C. Helicobacter pylori persistence: biology and disease. J Clin Invest 113 (2004) 321-333
49. Nwokolo C.U., Freshwater D.A., O'Hare P., et al. Plasma ghrelin following cure of Helicobacter pylori. Gut 52 (2003) 637-640
50. Roper J., Francois F., Shue P.L., et al. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab 93 (2008) 2350-2357
51. Anderson L.A., Murphy S.J., Johnston B.T., et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 57 (2008) 734-739
52. Wang C., Yuan Y., and Hunt R.H. Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis. Am J Gastroenterol 104 (2009) 491-501
53. Corley D.A., Kubo A., Levin T.R., et al. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 57 (2008) 727-733
54. Watson D.I., and Lally C.J. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community. World J Surg 33 (2009) 88-94
55. Nilsson M., Johnsen R., Ye W., et al. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 39 (2004) 1040-1045
56. Pandeya N., Williams G.M., Green A.C., et al. Do low control response rates always affect the findings?. Assessments of smoking and obesity in two Australian case-control studies of cancer. Aust N Z J Public Health 33 (2009) 312-319